Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity.

In a study to combine the transition state analogue concept with the principle of catalytic site spanning, a series of peptide-derived transition state analogue (TSA) inhibitors of thrombin has been synthesized and tested. In the sequence H-D-Phe-Pro-Arg-Gly-OH (2) the Arg-Gly amide bond has been replaced by three classes of transition state analogues, being the ketomethylene, the hydroxyethylene and the hydroxymethylene amide bond replacements. Compound 12a, in which the amide bond has been replaced by the ketomethylene group, was found to be the most potent thrombin inhibitor of the series studied. Subsequently, penta- and hexapeptide sequences with good affinity for thrombin were developed, i.e. H-D-Phe-Pro-Arg-Gly-Phe-OH (16) and H-D-Phe-Pro-Arg-Gly-Phe-Lys-OH (26). In these sequences the Arg-Gly amide bond was then replaced by the ketomethylene group. The resulting compounds 43a and 47a, respectively, were evaluated in vitro as inhibitors of thrombin and factor Xa. Compound 47a was found to be the most potent thrombin inhibitor of the series studied (Ki = 29 nM). The combination of the transition state analogue concept and the principle of peptide elongation (tetrapeptide-->hexapeptide) yields thrombin inhibitors of high potency and selectivity. The effects of these two alterations reinforce each other indicating a synergistic effect. This might be rationalized by entropy factors.

[1]  H Oschkinat,et al.  The interaction of thrombin with fibrinogen. A structural basis for its specificity. , 1992, European journal of biochemistry.

[2]  H. Ottenheijm,et al.  A one-pot N-protection of L-arginine. , 1991 .

[3]  D. Schirlin,et al.  General synthesis of polyfunctionalized fluoromethyleneketone retroamides as potential inhibitors of thrombin , 1991 .

[4]  R. Wolfenden,et al.  Transition State Analogues for Enzyme Catalysis , 1969, Nature.

[5]  Y. Konishi,et al.  A new class of potent thrombin inhibitors that incorporates a scissile pseudopeptide bond , 1991, FEBS letters.

[6]  J. L. Kurz.  Transition states as acids and bases , 1972 .

[7]  R. Wolfenden,et al.  Transition-state analogues , 1991 .

[8]  J. Greenstein,et al.  Studies on Arginine Peptides. I. Intermediates in the Synthesis of N-Terminal and C-Terminal Arginine Peptides* , 1957 .

[9]  W. Rutter,et al.  Converting trypsin to chymotrypsin: the role of surface loops. , 1992, Science.

[10]  E. Lunney,et al.  Novel synthesis of (S)-1-[5-(benzoylamino)-1,4-dioxo-6-phenylhexyl]-L-proline and analogues: potent angiotensin converting enzyme inhibitors. , 1981, Journal of medicinal chemistry.

[11]  G. Wipff.  Computational approaches in supramolecular chemistry , 1994 .

[12]  Chuan Yi Tang,et al.  A 2.|E|-Bit Distributed Algorithm for the Directed Euler Trail Problem , 1993, Inf. Process. Lett..

[13]  R. Huber,et al.  The Geometry of the Reactive Site and of the Peptide Groups in Trypsin, Trypsinogen and its Complexes with Inhibitors , 1983 .

[14]  S Bajusz,et al.  Study of the specificity of thrombin with tripeptidyl-p-nitroanilide substrates. , 2005, European journal of biochemistry.

[15]  Aalt Bast,et al.  Comprehensive medicinal chemistry , 1991 .

[16]  G. Whitesides,et al.  Kinetic resolution of unnatural and rarely occurring amino acids: enantioselective hydrolysis of N-acyl amino acids catalyzed by acylase I , 1989 .

[17]  R. Kikumoto,et al.  Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion. , 1981, Biochemical and biophysical research communications.

[18]  E. Wünsch,et al.  Zur Synthese des Glucagons, XI. Darstellung der Sequenz 16–23 , 1967 .

[19]  R. Kikumoto,et al.  A new series of synthetic thrombin-inhibitors (OM-inhibitors) having extremely potent and selective action. , 1976, Thrombosis research.

[20]  Garland R. Marshall,et al.  Peptides: Chemistry, Structure and Biology , 1990 .

[21]  J. Stürzebecher,et al.  Cyclic amides of N alpha-arylsulfonylaminoacylated 4-amidinophenylalanine--tight binding inhibitors of thrombin. , 1983, Thrombosis research.

[22]  M. Dioszegi,et al.  Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H. , 1990, Journal of medicinal chemistry.

[23]  M. García-López,et al.  Synthesis of ketomethylene dipeptides containing basic amino acid analogues at c-terminus , 1988 .

[24]  J. DiMaio,et al.  Synthesis of a homologous series of ketomethylene arginyl pseudodipeptides and application to low molecular weight hirudin-like thrombin inhibitors. , 1992, Journal of medicinal chemistry.

[25]  E. L. Smithwick,et al.  A new synthesis of N alpha,NG,G-tribenzyloxycarbonyl-L-arginine and related derivatives. , 1974, Journal of Organic Chemistry.

[26]  Linus Pauling,et al.  Molecular Architecture and Biological Reactions , 1946 .

[27]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[28]  E. Shaw,et al.  D-Phe-Pro-ArgCH2C1-A selective affinity label for thrombin. , 1979, Thrombosis research.

[29]  G. Claeson,et al.  Synthesis and biological activity of ketomethylene pseudopeptide analogues as thrombin inhibitors. , 1992, Journal of medicinal chemistry.

[30]  R. Knabb,et al.  The selective inhibition of thrombin by peptides of boroarginine. , 1990, The Journal of biological chemistry.